• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR G4 STEERABLE GUIDING CATHETER; CATHETER, STEERABLE Back to Search Results
Catalog Number SGC0704
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 01/28/2022
Event Type  Injury  
Event Description
Patient id (b)(4).This is filed for access site bleeding.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4+.Patient anatomy included a rotated heart, mitral annular calcification, thickened leaflets, bi-leaflet prolapse, thick and dense chords in the ventricle and a deep scallop between posterior 1/posterior 2.Visualization was difficult due to shadowing and the rotated heart.The clip delivery system (cds) was advanced into the patient anatomy and the anterior leaflet became caught on the grippers.Trouble shooting was performed; however, the clip (xtw) was unable to be freed.Additional troubleshooting was not performed, as the physician did not want to get the clip caught in the chordae.The clip was implanted at the same location where the anterior leaflet was caught.It was suspected that there was a small chordal tear and a new flail.A second clip (xt) was then implanted and the mr was reduced to grade 2-3+.Post procedure, minor bleeding was noted at the vessel access site.Manual pressure was applied, as well as a sand bag.Additionally, the patient experienced hypotension post procedure and a fluid bolus was administered.One day post procedure, the patient experienced supraventricular tachycardia (svt) and fever.No intervention was performed as treatment of the svt, but tylenol as administered for the fever.No infection was noted.The hypotension resolved on (b)(6) 2022.The svt and fever resolved on (b)(6) 2022.On (b)(6) 2022, an epinephrine/lidocaine subcutaneous injection was administered.The bleeding resolved on (b)(6) 2022.No additional information was provided.
 
Manufacturer Narrative
The customer reported the device was discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The additional device referenced is filed under a separate medwatch report number.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect of hemorrhage, as listed in the electronic g4 mitraclip system instructions for use (ifu), is a known possible complication associated with mitraclip procedures.The investigation was unable to determine a cause for the reported hemorrhage.The reported unexpected medical interventions and medication required were results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G4 STEERABLE GUIDING CATHETER
Type of Device
CATHETER, STEERABLE
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13908532
MDR Text Key289021212
Report Number2024168-2022-03176
Device Sequence Number1
Product Code DRA
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K190167
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/22/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/25/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/03/2022
Device Catalogue NumberSGC0704
Device Lot Number11004R101
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/31/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/04/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age83 YR
Patient SexFemale
Patient Weight61 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-